Biodefense

Emergent BioSolutions is a global specialty biopharmaceutical company focused on providing preparedness and response solutions for public health threats, including chemical, biological, radiological, nuclear, and explosive (CBRNE) threats and emerging infectious diseases. The company is a primary supplier of medical countermeasures to the U.S. Strategic National Stockpile, most notably providing the only FDA-licensed anthrax vaccine, BioThrax. Beyond its core biodefense portfolio, Emergent has expanded into commercial markets with products like Narcan (naloxone) for opioid overdose reversal and vaccines for travel health. The company also operates a significant contract development and manufacturing organization (CDMO) business, providing services to other biotech and pharmaceutical partners.